Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-05-11 3:31:26 am | TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update | GlobeNewsWire |
| 2023-05-08 1:5:0 pm | TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GlobeNewswire |
| 2023-04-15 6:6:24 am | Companies Like TCR2 Therapeutics (NASDAQ:TCRR) Could Be Quite Risky | Simply Wall St. |
| 2023-03-23 3:30:0 am | TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update | GlobeNewswire |
| 2023-03-06 3:0:0 am | Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors | GlobeNewswire |
| 2023-03-06 3:0:0 am | Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors | Newsfile |
Please consider a small donation if you think this website provides you with relevant information